Correction: Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease
Format: | Article |
---|---|
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783600/?tool=EBI |
Similar Items
-
Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease
by: Michael S. Wolfe
Published: (2021-01-01) -
The Binding of Different Substrate Molecules at the Docking Site and the Active Site of γ-Secretase Can Trigger Toxic Events in Sporadic and Familial Alzheimer’s Disease
by: Željko M. Svedružić, et al.
Published: (2023-01-01) -
γ-secretase inhibitors and modulators induce distinct conformational changes in the active sites of γ-secretase and signal peptide peptidase
by: Gertsik, Natalya, et al.
Published: (2015) -
Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition
by: Noah Federman
Published: (2022-09-01) -
Structural Analysis of the Simultaneous Activation and Inhibition of γ-Secretase Activity in the Development of Drugs for Alzheimer’s Disease
by: Željko M. Svedružić, et al.
Published: (2021-04-01)